InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Haas Jason, Director. Insider active across 2 companies, notably Ligand Pharmaceuticals INC. In total, 12 filings have been recorded. Split: 1 buy · 2 sells. Total volume traded: €1.8m. History available since 29 June 2022. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Jason Haas is Administrateur. He is linked to Syros Pharmaceuticals, Inc., where he is Chief Financial Officer, and to Ligand Pharmaceuticals INC, where he is Director. The 10 filings on record cover the period from 2022-06-30 to 2025-06-10, and the recent filings show mainly attributions.